Results 141 to 150 of about 14,135 (164)

[Research Advances in Targeting the YAP/TAZ Signaling Pathway 
to Improve Cancer Immunotherapy]. [PDF]

Zhongguo Fei Ai Za Zhi
Zhang P, Zhan Y.
europepmc   +1 more source

[Clinical features and immunotherapy for children with loss-of-function/gain-of-function mutations in the <i>STAT</i> gene: an analysis of 10 cases]. [PDF]

Zhongguo Dang Dai Er Ke Za Zhi
Li HW, Wang YH, Wu SZ, Zhang BY, Xu SH, Xu JX, Huang ZH, Lu CY, Chen DH.   +8 more
europepmc   +1 more source

Peripheral blood inflammatory markers as predictive and prognostic indicators in neoadjuvant immunotherapy for non-small cell lung cancer. [PDF]

Zhong Nan Da Xue Xue Bao Yi Xue Ban
Peng Y, Zeng Y, Zhang Y, Fan D, Wang S, Deng C, Ma F, Qiu Z, Chen C, Hu Y, Hu C, Liu W, Wu F.   +12 more
europepmc   +1 more source

[A risk prediction model for prognosis and immunotherapy response in prostate cancer patients based on immunosuppressive neutrophil Neu_2 subsets]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Chen Z, Zhou J, Tan L, Huang Z, Xue K, Chen M.   +5 more
europepmc   +1 more source

[Case Report and Literature Review of Severe Anemia Secondary to Chemotherapy 
Combined with PD-1 Monoclonal Antibody Immunotherapy for Lung Adenocarcinoma]. [PDF]

Zhongguo Fei Ai Za Zhi
Hu Y, Zhao J, Gao X, Xu Y, Wang M.
europepmc   +1 more source

[FCN3 Can Serve as A Potential Biomarker for Prognosis and 
Immunotherapy of Lung Squamous Cell Carcinoma]. [PDF]

Zhongguo Fei Ai Za Zhi
Li W, Zu L, Xu S.
europepmc   +1 more source

[Case Report: Histological Transformation to Atypical Carcinoid in RET Fusion-positive NSCLC Following Immune Therapy Resistance]. [PDF]

Zhongguo Fei Ai Za Zhi
Zhang Y, Zhang H, Zhong W, Chen M, Wang M.   +4 more
europepmc   +1 more source

[Analysis of Efficacy and Safety of Neoadjuvant Immunochemotherapy in Patients
with Stage IB-IIIB Non-small Cell Lung Cancer]. [PDF]

Zhongguo Fei Ai Za Zhi
Li Z, Wang X, Wang Y, Cui Z, Wang X, Li X, Jiang G, Wang X.   +7 more
europepmc   +1 more source

[A pan-cancer analysis of PYCR1 and its predictive value for chemotherapy and immunotherapy responses in bladder cancer]. [PDF]

Nan Fang Yi Ke Da Xue Xue Bao
Li Y, Song X, Sun R, Dong X, Liu H.
europepmc   +1 more source

Nano-Bacillus Calmette-Guérin immunotherapies for improved bladder cancer treatment. [PDF]

J Zhejiang Univ Sci B
Zeng S, Xing S, Zhang Y, Wang H, Liu Q.
europepmc   +1 more source